CO2 Laser Therapy for the Treatment of GSM in Patients With Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

June 30, 2023

Study Completion Date

December 30, 2023

Conditions
Breast CancerGenitourinary Syndrome of Menopause
Interventions
DEVICE

Fractional/Pixel CO2 laser

"The treatment is done with a specialized vaginal applicator which allows treatment of vagina, using the Femilift fractional micro ablative CO2 laser system (Alma Lasers, Israel), according to the usual protocol (Laser mode: Pulse, Energy: 40-80 mj/pulse).~Before treatment, 5ml of topical anesthetic ointment (10% lidocaine in Vaseline base) will be spread in the vagina and on the vestibule for 30 minutes in both groups to avoid pain from the laser, as well as to allow the comparison between the groups (patients in both groups will not experience pain and therefore will remain blinded to their allocation)."

Trial Locations (1)

73133

Ahinoam Lev-Sagie, Lapid

All Listed Sponsors
lead

Hadassah Medical Organization

OTHER

NCT04517370 - CO2 Laser Therapy for the Treatment of GSM in Patients With Breast Cancer | Biotech Hunter | Biotech Hunter